These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36307419)

  • 1. A doxycycline- and light-inducible Cre recombinase mouse model for optogenetic genome editing.
    Vizoso M; E J Pritchard C; Bombardelli L; van den Broek B; Krimpenfort P; Beijersbergen RL; Jalink K; van Rheenen J
    Nat Commun; 2022 Oct; 13(1):6442. PubMed ID: 36307419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of a tTA-dependent photoactivatable Cre recombinase knock-in mouse model for optogenetic genome engineering.
    Takao T; Hiraoka Y; Kawabe K; Yamada D; Ming L; Tanaka K; Sato M; Takarada T
    Biochem Biophys Res Commun; 2020 May; 526(1):213-217. PubMed ID: 32204914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photoactivatable Cre recombinase 3.0 for in vivo mouse applications.
    Morikawa K; Furuhashi K; de Sena-Tomas C; Garcia-Garcia AL; Bekdash R; Klein AD; Gallerani N; Yamamoto HE; Park SE; Collins GS; Kawano F; Sato M; Lin CS; Targoff KL; Au E; Salling MC; Yazawa M
    Nat Commun; 2020 May; 11(1):2141. PubMed ID: 32358538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A photoactivatable Cre-loxP recombination system for optogenetic genome engineering.
    Kawano F; Okazaki R; Yazawa M; Sato M
    Nat Chem Biol; 2016 Dec; 12(12):1059-1064. PubMed ID: 27723747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stable Transgenic Mouse Strain with Enhanced Photoactivatable Cre Recombinase for Spatiotemporal Genome Manipulation.
    Li H; Wu Y; Qiu Y; Li X; Guan Y; Cao X; Liu M; Zhang D; Huang S; Lin L; Hui L; Ma X; Liu M; Zhang X; Wang L; Li D
    Adv Sci (Weinh); 2022 Dec; 9(34):e2201352. PubMed ID: 36266974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single-chain and fast-responding light-inducible Cre recombinase as a novel optogenetic switch.
    Duplus-Bottin H; Spichty M; Triqueneaux G; Place C; Mangeot PE; Ohlmann T; Vittoz F; Yvert G
    Elife; 2021 Feb; 10():. PubMed ID: 33620312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inducible and coupled expression of the polyomavirus middle T antigen and Cre recombinase in transgenic mice: an in vivo model for synthetic viability in mammary tumour progression.
    Rao T; Ranger JJ; Smith HW; Lam SH; Chodosh L; Muller WJ
    Breast Cancer Res; 2014 Jan; 16(1):R11. PubMed ID: 24457046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A non-invasive far-red light-induced split-Cre recombinase system for controllable genome engineering in mice.
    Wu J; Wang M; Yang X; Yi C; Jiang J; Yu Y; Ye H
    Nat Commun; 2020 Jul; 11(1):3708. PubMed ID: 32709899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Podocyte cell-specific expression of doxycycline inducible Cre recombinase in mice.
    Juhila J; Roozendaal R; Lassila M; Verbeek SJ; Holthofer H
    J Am Soc Nephrol; 2006 Mar; 17(3):648-54. PubMed ID: 16467448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generalized tetracycline induced Cre recombinase expression through the ROSA26 locus of recombinant mice.
    Bäckman CM; Zhang Y; Malik N; Shan L; Hoffer BJ; Westphal H; Tomac AC
    J Neurosci Methods; 2009 Jan; 176(1):16-23. PubMed ID: 18801387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetracycline response element driven Cre causes ectopic recombinase activity independent of transactivator element.
    Lewis KT; Oles LR; MacDougald OA
    Mol Metab; 2022 Jul; 61():101501. PubMed ID: 35452876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Light-Inducible Recombinases for Bacterial Optogenetics.
    Sheets MB; Wong WW; Dunlop MJ
    ACS Synth Biol; 2020 Feb; 9(2):227-235. PubMed ID: 31961670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transgenic mouse with high Cre recombinase activity in all prostate lobes, seminal vesicle, and ductus deferens.
    Jin C; McKeehan K; Wang F
    Prostate; 2003 Oct; 57(2):160-4. PubMed ID: 12949940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limitations of Tamoxifen Application for In Vivo Genome Editing Using Cre/ER
    Ilchuk LA; Stavskaya NI; Varlamova EA; Khamidullina AI; Tatarskiy VV; Mogila VA; Kolbutova KB; Bogdan SA; Sheremetov AM; Baulin AN; Filatova IA; Silaeva YY; Filatov MA; Bruter AV
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Timing the doxycycline yields different patterns of genomic recombination in brain neurons with a new inducible Cre transgene.
    Lindeberg J; Mattsson R; Ebendal T
    J Neurosci Res; 2002 Apr; 68(2):248-53. PubMed ID: 11948670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precise optical control of gene expression in
    Davis L; Radman I; Goutou A; Tynan A; Baxter K; Xi Z; O'Shea JM; Chin JW; Greiss S
    Elife; 2021 Aug; 10():. PubMed ID: 34350826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practical use of advanced mouse models for lung cancer.
    Safari R; Meuwissen R
    Methods Mol Biol; 2015; 1267():93-124. PubMed ID: 25636466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stringent doxycycline dependent control of CRE recombinase in vivo.
    Schönig K; Schwenk F; Rajewsky K; Bujard H
    Nucleic Acids Res; 2002 Dec; 30(23):e134. PubMed ID: 12466566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repetitive short-pulsed illumination efficiently activates photoactivatable-Cre as continuous illumination in embryonic stem cells and pre-implantation embryos of transgenic mouse.
    Kishi K; Koyama H; Oka S; Kato A; Sato M; Fujimori T
    Genesis; 2021 Dec; 59(12):e23457. PubMed ID: 34687271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mouse Model for Optogenetic Genome Engineering.
    Takao T; Yamada D; Takarada T
    Acta Med Okayama; 2022 Feb; 76(1):1-5. PubMed ID: 35236992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.